Archive - Clear Thinking with Danny Lieberman

You can’t scale clinical success on unreliable data

CROs protect their margins — not your biomarkers. Here’s how to flip the script.

Aug 1 •

Danny Lieberman

July 2025

Trade Off or Die

Jul 25 •

Danny Lieberman

Are you shaping the future of techbio?

Join the leaders on Life Sciences Today.

Jul 24 •

Danny Lieberman

Do You Treat Your Clinical Data Like Garbage?

How the CRO Industry Destroys the Core Asset of Life Science Companies

Jul 18 •

Danny Lieberman

Good partner-bad partner

Don’t rely on your gut

Jul 11 •

Danny Lieberman

Take a deep breath.

There is an AI that makes a universal health record in America - Happy July 4th!

Jul 4 •

Danny Lieberman

June 2025

Are Real-World Data Companies Just $150 Burger Joints?

What Flatiron Health teaches techbio founders about margin, scale, and survivability.

Jun 27 •

Danny Lieberman

Drug Commercialization and Percolation Theory

How Sorcero Gets It Right – And Why You Don’t Need to Go Viral

Jun 20 •

Danny Lieberman

How to make money in rare diseases

Lessons from a classical pianist from Donetsk

Jun 13 •

Danny Lieberman

How to Make a Masterpiece

Change your mindset

Jun 6 •

Danny Lieberman

May 2025

Bank of America sucks

Design your team for AI

May 30 •

Danny Lieberman

If You Love, You Will Grow

3 rules for doing great work

May 23 •

Danny Lieberman

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts